Study guide

2.4 Bioburden & Infection Assessment

ABWM Certified Wound Specialist CWS

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Exam Overview

1.1 About the ABWM CWS Exam 1.2 How to Use This Study Guide & Blueprint Strategy

2 Chapter 2: Comprehensive Patient & Wound Assessment

2.1 Patient History & Systemic Risk Factors 2.2 Physical Examination & Anatomical Wound Classification 2.3 Quantitative Wound Measurement & Documentation 2.4 Bioburden & Infection Assessment

3 Chapter 3: Vascular Assessment & Diagnostic Testing

Section 3.1: Ankle-Brachial Index (ABI) & Toe-Brachial Index (TBI) Interpretation Section 3.2: Advanced Vascular Diagnostics Section 3.3: Neuropathic & Sensory Assessment

4 Chapter 4: Laboratory, Imaging & Diagnostic Approaches

Section 4.1: Laboratory Evaluation in Wound Care Section 4.2: Imaging Modalities for Wounds & Bone Section 4.3: Differential Diagnosis of Recalcitrant & Atypical Wounds

5 Chapter 5: Physiology of Wound Healing & Tissue Repair

5.1 Hemostasis & Inflammatory Phase Dynamics 5.2 Proliferative & Remodeling Phases 5.3 Growth Factors & Extracellular Matrix (ECM)

6 Chapter 6: Biofilm Biology & Wound Bed Preparation

6.1 Biofilm Pathophysiology & Management Strategies 6.2 TIME Framework & Wound Bed Preparation 6.3 Moisture Balance & Exudate Management

7 Chapter 7: Pressure Injuries & Moisture-Associated Skin Damage

7.1 Pressure Injury Pathophysiology & NPIAP Staging 7.2 Risk Assessment Tools & Support Surface Selection 7.3 Moisture-Associated Skin Damage (MASD) & Incontinence-Associated Dermatitis

8 Chapter 8: Lower Extremity Ulcers (Venous, Arterial & Mixed)

Section 8.1: Venous Leg Ulcers & CEAP Classification Section 8.2: Arterial Ulcers & Peripheral Artery Disease Section 8.3: Mixed Venous-Arterial Ulcers & Lymphedema

9 Chapter 9: Diabetic Foot Ulcers & Neuropathic Wounds

Section 9.1: Diabetic Foot Ulcer Pathophysiology & Classification Section 9.2: Diabetic Foot Infection & Osteomyelitis Management

10 Chapter 10: Thermal Injuries, Surgical Wounds & Special Etiologies

Section 10.1: Burn Injuries & Thermal Damage Section 10.2: Surgical Wounds, Dehisced Incisions & Fistulas Section 10.3: Dermatological, Pediatric & Miscellaneous Wound Types

11 Chapter 11: Debridement & Topically Applied Therapies

Section 11.1: Debridement Modalities & Selection Section 11.2: Wound Dressing Selection & Categories Section 11.3: Topical Antimicrobial Agents & Antiseptics

12 Chapter 12: Compression Therapy & Advanced Off-Loading

Section 12.1: Compression Therapy Modalities & Science Section 12.2: Off-Loading Devices & Biomechanical Protection

13 Chapter 13: Advanced & Adjunctive Wound Therapies

Section 13.1: Negative Pressure Wound Therapy (NPWT) Section 13.2: HBOT, Biophysical Agents & Advanced Biologics Section 13.3: Systemic Nutrition, Hydration & Pain Management

14 Chapter 14: Professional Practice, Reimbursement & Interprofessional Care

14.1 Professional Ethics, Scope of Practice & ABWM Guidelines 14.2 Documentation, Coding & Reimbursement Standards 14.3 Interprofessional Team Roles & Quality Improvement

2.4 Bioburden & Infection Assessment

Key Takeaways Explain This Topic AI

The wound bioburden continuum progresses sequentially from contamination and colonization to critical colonization (local infection) and invasive systemic infection.

The NERDS framework identifies surface/local infection (Non-healing, Exudate increase, Red/bleeding granulation, Debris, Smell) requiring topical antimicrobial therapy and wound bed prep.

The STONEES framework identifies deep/systemic tissue infection (Size increase, Temperature elevation, Os exposed, New breakdown, Exudate, Erythema/Edema >2 cm, Smell) requiring systemic antimicrobial therapy and surgical evaluation.

The Levine technique is the validated, evidence-based swab culture protocol requiring wound cleansing followed by firm rotation over a 1 cm² area of clean, viable granulation tissue to express fluid.

Full-thickness punch tissue biopsy remains the gold-standard diagnostic method for quantifying bacterial bioburden (>10⁵ CFU/gram tissue) and diagnosing invasive soft tissue infection.

Last updated: July 2026

Bioburden & Infection Assessment

All open cutaneous wounds are exposed to environmental microorganisms; however, the presence of bacteria does not automatically indicate infection. The Certified Wound Specialist must accurately diagnose the patient's position along the wound bioburden continuum to avoid two major clinical errors: over-prescribing systemic antibiotics for non-infected colonized wounds, and failing to recognize deep invasive soft tissue infection. Utilizing structured clinical criteria (NERDS vs. STONEES) and executing validated microbiological sampling techniques (Levine swab vs. punch biopsy) are essential competencies in advanced wound care.

1. The Wound Bioburden Continuum

The relationship between host defenses and microbial populations exists along a dynamic spectrum:

Contamination: Microorganisms are present on the wound surface without replicating or host tissue interaction. All open wounds are contaminated. Healing proceeds normally without host immune activation.

Colonization: Microorganisms attach, multiply, and form persistent populations on the wound bed without causing host cell damage or clinical immune responses. Healing continues unimpeded.

Critical Colonization (Local Infection): Microorganisms proliferate to a threshold where local host defenses are challenged. Bacteria release exotoxins and endotoxins that disrupt cellular repair, prolong the inflammatory phase, and cause subtle local tissue breakdown without spreading erythema.

Invasive / Systemic Infection: Microorganisms invade viable deep tissue, lymphatic channels, and vascular structures, triggering an overt inflammatory immune response. Bacteria spread into surrounding soft tissues ( > 2 cm >2\text{ cm} > 2 cm erythema) and can induce Systemic Inflammatory Response Syndrome (SIRS) or sepsis.

  • 2. Clinical Signs: Classic vs. Subtle Signs of Infection
  • Classic Signs of Infection (Acute Wounds)

In acute, surgical, or traumatic wounds, infection manifests with classic inflammatory signs:

Rubor (spreading erythema), Calor (localized heat), Dolor (disproportionate pain), Tumor (edema/swelling), and Functio Laesa (loss of function).

Subtle Signs of Infection (Chronic & Neuropathic Wounds)

In chronic wounds or immunocompromised/diabetic patients, classic inflammatory signs are frequently blunted due to impaired leukocyte responses and poor vascularity. Clinicians must recognize subtle markers of critical colonization:

Stalled healing velocity over 2 to 4 weeks.

Unexpected breakdown or pocketing of healthy granulation tissue.

Granulation tissue that becomes dark red, friable, and bleeds easily upon contact.

Abrupt change in exudate volume (copious) or character (seropurulent to purulent).

New onset of foul odor upon dressing removal.

Unexpected increase in local wound pain or tenderness.

3. Diagnostic Frameworks: NERDS vs. STONEES Criteria

To differentiate surface local infection from deep invasive infection and guide targeted therapy, clinicians employ the validated NERDS and STONEES clinical assessment tools.

NERDS Criteria (Surface / Critical Colonization / Local Infection)

The presence of 3 or more NERDS clinical signs indicates surface critical colonization requiring topical antimicrobial therapy (e.g., silver dressings, cadexomer iodine, honey, PHMB) and sharp debridement:

N — Non-healing wound: Stalled healing progress over 2 to 4 weeks.

E — Exudate increase: Sudden increase in exudate volume.

R — Red & bleeding granulation: Friable, dark, easily bleeding granulation tissue.

D — Debris: Accumulation of necrotic debris and slough on the wound surface.

S — Smell: New onset of malodor.

STONEES Criteria (Deep / Surrounding Tissue Infection)

The presence of 3 or more STONEES clinical signs indicates deep tissue infection requiring systemic antibiotic therapy , diagnostic imaging (X-ray/MRI for osteomyelitis), and surgical consultation:

S — Size increasing: Wound expanding in length, width, or depth.

T — Temperature elevation: Periwound skin temperature elevated by > 3 ∘ F >3^\circ\text{F} > 3 ∘ F ( > 1.7 ∘ C >1.7^\circ\text{C} > 1. 7 ∘ C ) compared to contralateral control skin.

O — Os (Bone exposed): Bone visible in the wound bed or probeable with a sterile metal probe (positive Probe-to-Bone test).

N — New breakdown: Satellite ulcers or breakdown around wound margins.

E — Exudate: Copious, purulent, thick drainage.

E — Erythema & Edema: Spreading periwound erythema and induration extending > 2 cm >2\text{ cm} > 2 cm beyond wound margins.

S — Smell: Foul, pungent odor.

Diagnostic Framework Comparison Table

Assessment Framework Bioburden Level Key Clinical Checklist Items Primary Therapeutic Strategy Microbiological Culture Indication

NERDS Surface / Local Infection (Critical Colonization) Non-healing, Exudate increase, Red friable granulation, Debris, Smell Topical antimicrobials (silver, iodine, honey) and wound bed debridement Swab culture usually not indicated unless failing topical therapy

STONEES Deep Soft Tissue / Systemic Infection Size increase, Temp > 3 ∘ F >3^\circ\text{F} > 3 ∘ F , Os (bone), New breakdown, Exudate, Erythema > 2 cm >2\text{ cm} > 2 cm , Smell Systemic antibiotics , surgical debridement, advanced imaging Perform quantitative Levine swab culture or tissue biopsy prior to antibiotics

4. Microbiological Sampling Techniques

Obtaining a reliable microbiological culture is essential for guiding antibiotic selection. Culturing uncleansed surface pus or slough yields colonizing contaminants rather than true tissue pathogens.

Levine Technique for Swab Culture

The Levine technique is the evidence-based, validated gold standard for wound swab culturing. It demonstrates superior correlation with tissue biopsy results compared to random swabbing or the Z-stroke method:

Cleansing: Thoroughly cleanse the wound bed with sterile non-antiseptic normal saline to remove superficial debris, loose exudate, and residual topical medications.

Debridement: Remove superficial non-viable slough if present.

Site Selection: Identify a 1 cm 2 1\text{ cm}^2 1 cm 2 area of clean, viable granulation tissue free of eschar or slough.

Technique: Press the sterile swab tip firmly onto the 1 cm 2 1\text{ cm}^2 1 cm 2 target area with sufficient pressure to express fluid from deep within the wound tissue. Rotate the swab 360 ∘ 360^\circ 36 0 ∘ over the site.

Transport: Immediately place the swab into sterile transport media and submit for Gram stain, aerobic, and anaerobic cultures.

Punch Tissue Biopsy (Gold Standard)

Full-thickness tissue biopsy remains the absolute gold standard for quantifying tissue bioburden and diagnosing invasive infection:

Procedure: Under local anesthesia, a 3 mm or 4 mm dermal punch biopsy is taken from clean, viable tissue at the wound margin or bed, including dermis and subcutaneous fat.

Quantitative Threshold: Tissue is homogenized and quantitatively cultured. A concentration of > 10 5 >10^5 > 1 0 5 Colony-Forming Units (CFU) per gram of tissue (or > 10 3 CFU/g >10^3\text{ CFU/g} > 1 0 3 CFU/g for β \beta β -hemolytic Streptococcus ) defines invasive tissue infection and is strongly predictive of skin graft failure or wound breakdown.

Histopathology: Biopsy allows histopathological evaluation to confirm tissue invasion, vasculitis, or fungal hyphae penetration.